Health TrialsbyHealthPanel

Rhomboid Intercostal Sub Serratus Plane Block Versus Serratus Anterior Plane Block in Thoractomy

ConditionsThoracicPain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorYasser S Mostafa, MD

About this trial

The objective of the current study is to compare the efficacy of the analgesic effect of ultrasound-guided unilateral Rhomboid intercostal and sub serratus plane block (RISS) versus Serratus anterior plane block (SAPB) in Thoracotomy incision.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients aged 18-70 years.

Patients scheduled for unilateral Thoracotomy.

American Society of Anesthesiologists (ASA) physical status I-III.

Patients who are candidates for general anesthesia.

Disqualifiers

ASA PS class ≥ IV patients.

obese (BMI ≥ 35) patients.

Patients with uncontrolled cardiovascular.

patients with neurological deficits, cardiopulmonary, hepatorenal , or metabolic diseases; anticoagulants; any drug allergies.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Bupivacain

    Drug

    After the location will be confirmed through hydrodissection of 1 ml on the plane between the rhomboid major and the underlying intercostal muscles after confirming a negative aspiration via a a 22-gauge short bevel sonovisible needle (Spinocan, B. Braun Melsungen AG, Germany) using an in-plane technique then 10 ml of bupivacaine (concentration 0.25%) will be injected. and its spread will be manifested by the hydrodissection and widening of the plane visualized by ultrasound.

  • Ultrasound

    Device

    A linear US transducer (Phillips-Saronno Italy) was placed vertically 3 cm lateral to the midline to visualize back muscles: the trapezius above, the rhomboid major in the middle, and the erector-spinae muscle on the bottom, as well as the TPs with shimmering pleura in between.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Group RExperimental treatment 2 interventions
Group B: Group SActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Total opioid consumption

in microgram

Time frame
24 hours postoperatively.

Secondary outcomes

1

Total intraoperative opioid consumption

in microgram

Time frame
from begining of operation till 5 minutes after extubation
2

Visual analog pain score at rest

Ranging from 0 indicating no pain to 10 indicating extreme pain

Time frame
Immediately after the procedures
3

Visual analog pain score at cough

Ranging from 0 indicating no pain to 10 indicating extreme pain

Time frame
Immediately after the procedures
4

Visual analog pain score at rest

Ranging from 0 indicating no pain to 10 indicating extreme pain

Time frame
1 hour postoperatively.

Other outcomes

1

Age

in years

Time frame
5 minutes before entering operation department
2

Sex

Male of female

Time frame
5 minutes before entering operation department

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yasser S Mostafa, MD

Lead sponsor

Fayoum University Hospital

Sponsor institution

Source ClinicalTrials.gov
Apply now